Broadfin Capital’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SBH
Broadfin Capital's ANGO Position: Q4 2018 in Review
Broadfin Capital sold out of AngioDynamics (ANGO) in Q4 2018, closing a stake of 289,035 shares — an estimated $6.28M sold.
Broadfin Capital first reported a position in ANGO in Q2 2013 and held it in 21 quarters. The position peaked at $51.8M in Q2 2016. 174 funds tracked by Wall St. Rank hold ANGO as of Q4 2018.
- Broadfin Capital reported no remaining AngioDynamics position as of Q4 2018 after selling out during the quarter.
- Broadfin Capital sold 289,035 AngioDynamics shares in Q4 2018, an estimated $6.28M.
- Broadfin Capital first reported a position in AngioDynamics in Q2 2013 and held it in 21 quarters.
- Broadfin Capital's AngioDynamics position peaked at $51.8M in Q2 2016.
- 174 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2018.
Based on Broadfin Capital's 13F filing for Q4 2018, filed 14 Feb 2019.